[Pharmacotherapy in patients with ulcerative colitis].

Standard

[Pharmacotherapy in patients with ulcerative colitis]. / Scherer, Martin; Hardt, J; Blozik, Eva; Preiss, J C; Bokemeyer, B; Hüppe, A; Raspe, H.

in: Z GASTROENTEROL, Jahrgang 49, Nr. 7, 7, 2011, S. 820-826.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Scherer, M, Hardt, J, Blozik, E, Preiss, JC, Bokemeyer, B, Hüppe, A & Raspe, H 2011, '[Pharmacotherapy in patients with ulcerative colitis].', Z GASTROENTEROL, Jg. 49, Nr. 7, 7, S. 820-826. <http://www.ncbi.nlm.nih.gov/pubmed/21766260?dopt=Citation>

APA

Scherer, M., Hardt, J., Blozik, E., Preiss, J. C., Bokemeyer, B., Hüppe, A., & Raspe, H. (2011). [Pharmacotherapy in patients with ulcerative colitis]. Z GASTROENTEROL, 49(7), 820-826. [7]. http://www.ncbi.nlm.nih.gov/pubmed/21766260?dopt=Citation

Vancouver

Scherer M, Hardt J, Blozik E, Preiss JC, Bokemeyer B, Hüppe A et al. [Pharmacotherapy in patients with ulcerative colitis]. Z GASTROENTEROL. 2011;49(7):820-826. 7.

Bibtex

@article{fc012afcf2ed498daef911a5e8208469,
title = "[Pharmacotherapy in patients with ulcerative colitis].",
abstract = "Patients with ulcerative colitis experience various impairments. The pharmacological treatment of the disease comprises 5-aminosalicylic acid, corticosteroids as well as immunomodulatory and biological agents. Little self-reported data exist on the prescription of these drugs.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Adolescent, Young Adult, Prevalence, Germany/epidemiology, Anti-Inflammatory Agents/*therapeutic use, Adrenal Cortex Hormones/*therapeutic use, Biological Agents/therapeutic use, Colitis, Ulcerative/*drug therapy/*epidemiology, Immunologic Factors/*therapeutic use, Mesalamine/*therapeutic use, Prescriptions/*statistics & numerical data, Adult, Humans, Male, Aged, Female, Middle Aged, Adolescent, Young Adult, Prevalence, Germany/epidemiology, Anti-Inflammatory Agents/*therapeutic use, Adrenal Cortex Hormones/*therapeutic use, Biological Agents/therapeutic use, Colitis, Ulcerative/*drug therapy/*epidemiology, Immunologic Factors/*therapeutic use, Mesalamine/*therapeutic use, Prescriptions/*statistics & numerical data",
author = "Martin Scherer and J Hardt and Eva Blozik and Preiss, {J C} and B Bokemeyer and A H{\"u}ppe and H Raspe",
year = "2011",
language = "Deutsch",
volume = "49",
pages = "820--826",
journal = "Z GASTROENTEROL",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "7",

}

RIS

TY - JOUR

T1 - [Pharmacotherapy in patients with ulcerative colitis].

AU - Scherer, Martin

AU - Hardt, J

AU - Blozik, Eva

AU - Preiss, J C

AU - Bokemeyer, B

AU - Hüppe, A

AU - Raspe, H

PY - 2011

Y1 - 2011

N2 - Patients with ulcerative colitis experience various impairments. The pharmacological treatment of the disease comprises 5-aminosalicylic acid, corticosteroids as well as immunomodulatory and biological agents. Little self-reported data exist on the prescription of these drugs.

AB - Patients with ulcerative colitis experience various impairments. The pharmacological treatment of the disease comprises 5-aminosalicylic acid, corticosteroids as well as immunomodulatory and biological agents. Little self-reported data exist on the prescription of these drugs.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Adolescent

KW - Young Adult

KW - Prevalence

KW - Germany/epidemiology

KW - Anti-Inflammatory Agents/therapeutic use

KW - Adrenal Cortex Hormones/therapeutic use

KW - Biological Agents/therapeutic use

KW - Colitis, Ulcerative/drug therapy/epidemiology

KW - Immunologic Factors/therapeutic use

KW - Mesalamine/therapeutic use

KW - Prescriptions/statistics & numerical data

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Adolescent

KW - Young Adult

KW - Prevalence

KW - Germany/epidemiology

KW - Anti-Inflammatory Agents/therapeutic use

KW - Adrenal Cortex Hormones/therapeutic use

KW - Biological Agents/therapeutic use

KW - Colitis, Ulcerative/drug therapy/epidemiology

KW - Immunologic Factors/therapeutic use

KW - Mesalamine/therapeutic use

KW - Prescriptions/statistics & numerical data

M3 - SCORING: Zeitschriftenaufsatz

VL - 49

SP - 820

EP - 826

JO - Z GASTROENTEROL

JF - Z GASTROENTEROL

SN - 0044-2771

IS - 7

M1 - 7

ER -